FDMT (4D Molecular Therapeutics, Inc. Common Stock) Stock Analysis - Community
4D Molecular Therapeutics, Inc. Common Stock (FDMT) is a publicly traded Healthcare sector company. As of May 21, 2026, FDMT trades at $8.49 with a market cap of $437.29M and a P/E ratio of -3.28. FDMT moved +0.89% today. Year to date, FDMT is +16.03%; over the trailing twelve months it is +120.00%. Its 52-week range spans $2.24 to $12.34. Analyst consensus is strong buy with an average price target of $29.00. Rallies surfaces FDMT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade FDMT?
Rallies community data for FDMT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Rallies community data for FDMT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for FDMT?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for FDMT when enough community data is available.
Is FDMT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FDMT. It does not provide personalized investment advice.